NDRG2 expression and mutation in human liver and pancreatic cancers

doi:10.3748/wjg.v10.i23.3518

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3865)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

495

HTML

2997

Figures (1-3)

196

Tables (1-1)

177

Sum=3865

Dec 1, 2004 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (72)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Dec 1, 2004; 10(23): 3518-3521
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3518

Full Size Figure Download Figure

Figure 1 Expressions of NDRG2 mRNA in human liver cancer and pancreatic cancer. A: Representative agarose gels of RT-PCR-amplified NDRG2. M: DNA molecular weight marker; N: Normal tissue; C: Cancer tissue; B: Relative amount of NDRG2 mRNA was evaluated by the ratio of band optical density of NDRG2/GAPDH and the expression was significantly decreased in cancer (n = 29 for liver cancer, and 8 for pancreatic cancer respectively) vs normal tissues. ^aP<0.05, ^bP < 0.01 vs normal.

Citation: Hu XL, Liu XP, Lin SX, Deng YC, Liu N, Li X, Yao LB. NDRG2 expression and mutation in human liver and pancreatic cancers. World J Gastroenterol 2004; 10(23): 3518-3521
URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3518.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3518